- Lobbying
- Amy AND Redl
Lobbying Arrangements Results for 'Amy Redl'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Vaccine and generic biological issues and related appropriation issues, including vaccines for children, pandemic concerns, influenza vaccine issues, stockpile, bioterrorism, bioterrorism counterme... |
SANOFI PASTEUR, INC. (FORMERLY AVENTIS PASTEUR)
|
in-house lobbying | |||
Details Pharmacy reimbursement issues |
Senior Care Pharmacy Alliance
|
VENN STRATEGIES, LLC | |||
Details Pharmacy reimbursement issues |
Managed Health Care Associates, Inc.
|
VENN STRATEGIES, LLC | |||
Details Health care issues as they relate to the delivery of critical care services in the United States |
Roundtable on Critical Care Policy
|
VENN STRATEGIES, LLC | |||
Details Orphan drugs and rare diseases, matters related to drug reimbursement policy. Orphan drugs and rare disease matters |
BioMarin Pharmaceutical, Inc.
|
VENN STRATEGIES | |||
Details Health care issues related to home dialysis services. Medicare coverage of home dialysis for acute kidney injury patients. |
Alliance for Home Dialysis
|
VENN STRATEGIES | |||
Details General policy issues relating to academic medicine. |
UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION/UW HEALTH
|
VENN STRATEGIES | |||
Details Issues related to prescription-to- over the counter switch; issues related to influenza vaccines; issues related to 340B; issues related to Respiratory Syncytial Virus (RSV) access; issues related ... |
Sanofi US Services Inc.
|
in-house lobbying | |||
Details Legislation and other proposed policy change impacting S Corporation ESOPs. |
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA
|
VENN STRATEGIES | |||
Details General issues related to the bio-pharmaceutical sector, innovation, patient access, health care manufacturing, and pandemic preparedness/response. Measures related to U.S. international and corpor... |
Regeneron Pharmaceuticals, Inc.
|
VENN STRATEGIES |